Prevalence of Androgen Receptor Expression in Triple Negative Breast Cancers According To BRCA1 Mutation Status

被引：0
|
作者：
Torous, Vanda Farahmand
Schnitt, Stuart
Garber, Judy
Hacker, Michele
Poles, Emily
Alexander, Brian
Lee, Larissa
Collins, Laura
Tung, Nadine
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
164
引用
收藏
页码：44A / 44A
页数：1
相关论文
共 50 条
  • [1] Prevalence of Androgen Receptor Expression in Triple Negative Breast Cancers According To BRCA1 Mutation Status
    Torous, Vanda Farahmand
    Schnitt, Stuart
    Garber, Judy
    Hacker, Michele
    Poles, Emily
    Alexander, Brian
    Lee, Larissa
    Collins, Laura
    Tung, Nadine
    LABORATORY INVESTIGATION, 2015, 95 : 44A - 44A
  • [2] BRCA1 Expression in Triple Negative Sporadic Breast Cancers
    Galizia, Eva
    Giorgetti, Gessica
    Piccinini, Gina
    Santinelli, Alfredo
    Loretelli, Cristian
    Bianchi, Francesca
    Gagliardini, Daniela
    Carbonari, Giovanna
    Pisa, Eleonora
    Belvederesi, Laura
    Bracci, Raffaella
    Ferretti, Concetta
    Corradini, Fabio
    Cellerino, Riccardo
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 2010, 32 (01): : 24 - 29
  • [3] Basal Cytokeratin and Epidermal Growth Factor Receptor Expression Are Not Predictive of BRCA1 Mutation Status in Women With Triple-negative Breast Cancers
    Collins, Laura C.
    Martyniak, Anthony
    Kandel, Michaela J.
    Stadler, Zsofia K.
    Masciari, Serena
    Miron, Alexander
    Richardson, Andrea L.
    Schnitt, Stuart J.
    Garber, Judy E.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2009, 33 (07) : 1093 - 1097
  • [4] Correlation of BRCA1 mutation status with basal cytokeratin and epidermal growth factor receptor expression in women with "triple negative" breast cancers.
    Collins, L. C.
    Martyniak, A.
    Kandel, M.
    Miron, A.
    Harris, L.
    Richardson, A.
    Stadler, Z.
    Schnitt, S. J.
    Garber, J. E.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S178 - S178
  • [5] Imaging features of triple-negative breast cancers according to androgen receptor status
    Candelaria, Rosalind P.
    Adrada, Beatriz E.
    Wei, Wei
    Thompson, Alastair M.
    Santiago, Lumarie
    Lane, Deanna L.
    Huang, Monica L.
    Arribas, Elsa M.
    Rauch, Gaiane M.
    Symmans, W. Fraser
    Gilcrease, Michael Z.
    Huo, Lei
    Lim, Bora
    Ueno, Naoto T.
    Moulder, Stacy L.
    Yang, Wei Tse
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 114 : 167 - 174
  • [6] Is basal cytokeratin (CK) or epidermal growth factor receptor (EGFR) expression predictive of BRCA1 mutation status in women with triple negative breast cancers?
    Martyniak, A.
    Kandel, M. J.
    Masciari, S.
    Harris, L.
    Miron, A.
    Richardson, A.
    Schnitt, S. J.
    Garber, J. E.
    Collins, L. C.
    MODERN PATHOLOGY, 2007, 20 : 41A - 41A
  • [7] Is basal cytokeratin (CK) or epidermal growth factor receptor (EGFR) expression predictive of BRCA1 mutation status in women with triple negative breast cancers?
    Martyniak, A.
    Kandel, M. J.
    Stadler, Z.
    Masciari, S.
    Harris, L.
    Miron, A.
    Richardson, A.
    Schnitt, S. J.
    Garber, J. E.
    Collins, L. C.
    LABORATORY INVESTIGATION, 2007, 87 : 41A - 41A
  • [8] Triple negative breast cancer: microRNA expression profile and novel discriminators according to BRCA1 status
    Abdel-Sater, Fadi
    Najar, Mehdi
    Fayyad-Kazan, Hussein
    JOURNAL OF CELLULAR PHYSIOLOGY, 2020, 235 (06) : 5204 - 5212
  • [9] Androgen receptor expression in breast carcinomas arising in BRCA1 and BRCA2 mutation carriers
    O'Shea, A. M.
    Mulligan, A. M.
    Bane, A. L.
    Pinnaduwage, D.
    Andrulis, I. L.
    O'Malley, F. P.
    MODERN PATHOLOGY, 2008, 21 : 47A - 48A
  • [10] Androgen receptor expression in breast carcinomas arising in BRCA1 and BRCA2 mutation carriers
    O'Sheo, A. M.
    Mulligan, A. M.
    Bane, A. L.
    Pinnaduwage, D.
    Andrulis, I. L.
    O'Malley, E. P.
    LABORATORY INVESTIGATION, 2008, 88 : 47A - 48A
12345